Mike Branson

Mike Branson is the Chief Data Officer and Head of Statistical Sciences and Innovation at UCB, a global biopharmaceutical company. He holds a PhD in Biostatistics, as well as an MSc in Mathematical Statistics and a BSc in Mathematics/Statistics, bringing over 20 years of experience in the pharmaceutical industry to his role.2

In his position, Branson focuses on leveraging data analytics, machine learning, and artificial intelligence to enhance drug discovery, development, and patient care. His work emphasizes a question-led approach to data utilization, aiming to address critical questions related to patient treatment and outcomes rather than merely analyzing large data sets.13 This methodology is exemplified by UCB's collaboration with Stanford University on research into Hidradenitis Suppurativa, where they aim to improve understanding and treatment of this complex immunological condition.1

Branson's leadership is characterized by a commitment to innovation in statistical methods and data science, including the development of new machine learning techniques that can optimize clinical trial designs and patient stratification processes. His efforts are directed towards making data-driven decisions that accelerate the delivery of new treatments to patients.14